To study the prognostic factors in patients with hepatic metastasis from colorectal cancer after hepatectomy and preventive arterial infusion chemotherapy (AIC). We examined outcomes in 42 patients treated with preventive AIC and evaluated possible prognostic factors by investigating clinicopathological variables with double staining with hematoxylin-eosin and Victoria blue for hepatic metastasis. The cumulative survival rates of patients with primary lesions smaller than 5cm were significantly greater than those of patients with primary lesions 5cm or larger in diameter. However, the site of primary lesion, Dukes' classification, and vessel invasion of the primary lesion did not affect survival. Although the cumulative survival rates of patients with vessel invasion in hepatic metastases were significantly lower than those of patients without vessel invasion, survival did not differ significantly on the basis of other variables. In addition, the incidence of recurrence was significantly higher in patients with vessel invasion of the primary lesion or lymph node metastasis than in other patients. These results suggest that vessel invasion of hepatic metastasis and that of primary lesions is significantly correlated with cumulative survival rates and recurrence in the remnant liver and strongly indicate an increased risk of recurrence.
Introduction
Surgical resection is widely accepted as an effective method of treating hepatic metastasis from colorectal cancer (Fortner, Silvia et al., 1984; Hughes, Simon et al., 1986; Scheele, Stangl et al., 1990) . However, the incidence of recurrence in the remnant liver (RL) after resection remains high and can affect survival (Ekberg, Tranberg et al., 1987; Fortner, 1985; Nordlinger, Quilichini et al., 1987) . Arterial infusion chemotherapy (AIC) is often used to prevent recurrence of metastasis in RL after resection. We have Reprints to: Dr. Akihiko Tsuchida, Department of Surgery, Tokyo Medical University, 6-7-1, Nishi-Shinjuku, Shinjuku-Ku, Tokyo 160-0023, Japan. TEL: 81-3-3342-6111, FAX: 81-3-3340-4575, E-mail:akibobo@hotmail.com.
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previously reported that AIC after hepatectomy increases the rates of overall survival and disease-free survival (Aoki, Yasuda et al., 1994; Aoki, Koyanagi et al., 1996) . In the present study, we evaluated recurrence in the RL and possible factors affecting prognosis by investigating clinicopathological factors, especially vessel invasion in the tumor.
Patients and Methods
The subjects of this study were 42 patients who had undergone liver resection and AIC for metastases from colorectal cancer to the liver at the department of surgery, Tokyo Catheterization of the proper hepatic artery was performed at our hospital. The 5-fluorouracil (5-FU) was administered at a dosage of 250 to 1000mg/body/week, according to the volume of the RL. It was administered continuously unless there were severe adverse effects or catheter obstruction. The period of administration ranged from 3 to 28 months (mean, 11.1 months) and the number of treatments ranged from 3 to 90 (mean, 31.3 treatments). The total dose of 5-FU ranged from 2,500 to 45,000mg (mean, 15,583mg) .
Double staining with hematoxylin-eosin (HE) and Victoria blue (VB) was performed to examine invasion into blood vessels in the primary lesion (n=34) and in metastases (n=42). Based on the results of this examination, we investigated the correlation between each clinicopathological factor and survival, recurrence in the RL, and factors determining recurrence.
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Statistical analysis was performed with the t-test for differences between mean values for age and time until recurrence of liver and local lesions and with Fisher's exact probability test for comparisons between groups. Survival was calculated from the date of liver resection; cumulative survival curves were generated with the Kaplan-Meier method, and log-rank tests were used for statistical analysis. Differences with a p value less than 0.05 were considered as significant.
Results
The cumulative survival rate and clinicopathological factors in the primary lesion Survival was significantly better in patients with tumors less than 5cm than in those with tumors 5cm or larger in maximum diameter (P=0.027) ( Figure 1 ). However, the site of the primary lesion, Dukes' classification, and vessel invasion of the primary lesion did not affect survival.
Pathological findings in hepatic metastasis
Although hepatic vessel invasion in cancerous lesions could not be detected with ordinary HE staining, veins associated with elastic fibers were clearly visualized with HE and VB double staining, enabling intravenous invasion of tumor cells to be estimated easily ( Figure 2 ). Vessel invasion by metastatic tumors in liver was observed in 13 (31%) Figure 1 . Prognosis of patients with size of primary tumor less than 5cm and 5cm or greater in maximum diameter of the primary tumor (Kaplan Meier, log rank test). of 42 cases. In one of 13 cases, cancer cells were also identified in Glisson's bile duct adjacent to the main metastatic lesion, which was considered to be due to intrahepatic metastasis through the bile duct. Recurrence in the RL and cumulative survival rate
Tumor recurred in the RL in 20 (47.6%) of 42 patients. In 13 patients recurred metachronously, the time to recurrence ranged from six to 47 months (mean, 21.9 months). During AIC treatment local recurrence was also detected in seven patients (mean, 13.5 months) and pulmonary recurrence in eight patients (mean, 24.9 months) (Table I) . Patients with recurrence in the RL had significantly worse survival than did patients without recurrence (p=0.0099) (Figure 4 ). Of the patients with recurrence in the RL, two underwent re-resection of liver, two underwent re-resection of the lung, and one underwent simultaneous re-resection of the liver and the lung. The most common cause ANNALS OF Cancer Research and Therapy of death in 23 patients was recurrence in the RL in 15 cases, including six cases of synchronous recurrence in the liver and lung, followed by local recurrence only in three cases, pulmonary recurrence only in two cases, and other diseases in three cases.
Factors determining recurrence in the RL
The incidence of recurrence in the RL was significantly higher in cases with lymph node metastasis (p=0.0083) and in cases with vessel invasion of the primary lesion (p=0.00018). Tumor recurred in the RL in 10 (76.9%) of 13 patients with vessel invasion, but in only 10 (34.5%) of 29 patients without vessel invasion (p=0.0128). In contrast,
there was no significant correlation between recurrence in the RL and the site or size of the primary lesion, the timing of hepatic metastasis, the number of hepatic metastases, or the timing of local or pulmonary recurrence (Table I) . Furthermore, there was no statistical difference in the rates of vessel invasion in the RL in cases with vessel invasion or lymph node metastasis in the primary tumor (Table II) .
Discussion
Surgical resection of hepatic metastases from colorectal cancer prolongs survival in selected patients (Fortner, Silvia et al., 1984; Hughes, Simon et al., 1986; Scheele, Stangl et al., 1990) . Although various clinicopathological factors have been reported to affect survival, many reports have suggested that recurrence in the RL might be an important prognostic factor (Hughes, Simon et al., 1986; Kato, Umekita et al., 1995) . Reported rates of recurrence in the RL range from 30% to 70% (Ekberg, Tranberg et al., 1987; Fortner 1985; Nordlinger, Quilichini et al., 1987) . In the present study, the survival of patients with recurrence in the RL was also significantly worse than that of patients without recurrence. Therefore, controlling recurrence in the RL is extremely important for improving the survival of patients with hepatic metastases from colorectal cancer.
Several studies have found that AIC after resection of hepatic tumors helps to prevent recurrence in the RL and improves survival. Curley, Roh et al. (1992) have reported that recurrence in the RL occurred in nine (50%) of 18 patients treated with AIC, but also found that the recurrence rate was significantly lower than that in patients not undergoing AIC. Kinoshita, Ozaki et al. (1997) have reported that the 3-year and 5-year survival rates for overall 69 patients with liver metastasis from colorectal cancer were 16.2% and 6.8%, but were 55.6% and 29.6%, respectively, for 14 of these patients who underwent ANNALS OF Cancer Research and Therapy liver resection with AIC. Tsuji, Hamada et al. (1998) have also reported that in 14 patients who underwent preventive AIC, the 5-year survival rate was 77.5% and the 5-year recurrence rate in the RL was 14.4%. In contrast, Lorenz, Muller et al. (19998) have reported that in a randomized trial at 26 hospitals in Germany an expected 50% improvement in survival by the use of AIC was only 5% of patients and concluded that patient accrual was terminated. Furthermore, although individual hospitals in Japan have found that AIC is an effective adjuvant therapy after resection for synchronous hepatic metastasis, a multicenter survey by Kawahara and Hojyo (1999) found that AIC is not effective. We speculate that the discrepancies between these results are due to differences in the background factors of patients, in the AIC regimen, or in treatment at recurrence among institutions.
In addition, there have been several reports that AIC increases a chance for treatment of recurrence. Nakazaki, Watanabe et al. (1999) have reported that the frequency of recurrence in the RL in patients treated with AIC was 29.4% compared with 60.7% of patients not treated with AIC. Furthermore, re-resection of the liver could be performed to treat recurrence in the RL in four of five patients treated with AIC but in only two of 17 patients not treated with AIC. Hanada, Umekita et al. (1995) have reported that tumor recurred in the RL in 45.5% of patients treated with AIC, but concluded that AIC could delay recurrence because the cumulative disease-free rates in the RL at one, three, and five years were 80.9%, 49.8%, and 39.8% in patients receiving AIC but were 76%, 37.6% and 37.6% in patients not receiving AIC. The number of our cases in which reresection was possible suggests that AIC increases the possibility of re-resection and improves survival because AIC suppresses recurrence or development of the recurrent tumors or both.
The serosal invasion, vessel invasion and lymph node metastasis of the primary lesion (Jaeck, Bachellier et al., 1997; Adachi, Inomata et al., 1999) , detection time, number, surgical procedure and surgical margin of liver metastases (Cady, Jenkins et al., 1998; Yamamoto, Shimada et al., 1999; Nagashima, Oka et al., 1999; Jenkins, Millikan et al., 1997) , or the presence of extrahepatic involvements (Jenkins, Millikan et al., 1997) increased the rate of recurrence in the RL. However, these factors had no significant relations between primary and metastatic lesion. Masui, Ike et al. (1997) have suggested three mechanisms of metastastic recurrence in the RL as follows; 1) gross metastasis remaining on the surgical surface, 2) daughter metastasis from the gross metastasis existing over the surgical line, and 3) occult metastasis from the primary lesion existing before surgery. To determine mechanism of recurrence, resected hepatic tissue must be carefully examined. However, it is difficult to accurately determine the surgical margin histopathologically and to estimate whether metastastic recurrence in the RL has arisen from the original tumor or from occult metastases. Furthermore, judgment is inevitably influenced by subjective factors.
Some reports have suggested a strong relationship between vessel invasion of primary lesion and metastatic ability. To determine vessel invasion more objectively, staining with Elastica van Gieson or VB for elastic fibers of intratumoral veins should be performed in addition to normal HE staining (Inada, Shimokawa et al., 1991; Tsuchiya, Ando et al., 1995) . When such double staining was performed in the present study, we found a statistically significant difference between vessel invasion of hepatic metastasis and prognosis, and demonstrated a relationship with recurrence of metastasis in the remnant.
Prognostic factors have recently been analyzed based on pathological study of metastasis, but quite a few reports have objectively estimated vessel invasion with HE and VB double staining. However, an examination with normal staining by Yamamoto, Shimada et al. (1999) found that portal invasion, hepatic venous invasion and fibrous pseudocapsule of liver metastasis were poor predictors for survival. These findings suggest that the risk of metastatic recurrence into the surrounding liver tissue is high. Our results are consistent with the findings of these earlier reports and suggest that vessel invasion within hepatic metastases is a factor predicting survival and the recurrence of metastasis in the RL.
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This study has shown that metastastic recurrence in the RL develops frequently and decreases survival in patients with vessel invasion of the primary lesion, lymph node metastasis, and vessel invasion of hepatic metastases. Therefore, careful follow up is necessary to monitor possible recurrence after surgery in these patients.
